High frequency of K-ras codon 12 mutations in bronchoalveolar lavage fluid of patients at high risk for second primary lung cancer

Clinical Cancer Research

Volumn 3, Issue 3, 1997, Pages 479-482

  Scott, Frank M ^a   Modali, Rama ^b   Lehman, Teresa A ^b   Seddon, Michael ^b   Kelly, Karen ^c   Dempsey, Edward C ^d   Wilson, Vincent ^e   Tockman, Melvyn S ^f   Mulshine, James L ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b BioServe Biotechnologies Ltd   (United States)

^c UNIVERSITY OF COLORADO   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e LOUISIANA STATE UNIVERSITY   (United States)

^f JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CODON; HIGH RISK PATIENT; HUMAN; HUMAN TISSUE; LUNG CANCER; LUNG LAVAGE; MAJOR CLINICAL STUDY; MUTATION; ONCOGENE K RAS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SECOND CANCER;

BRONCHOALVEOLAR LAVAGE FLUID; CARCINOMA, NON-SMALL-CELL LUNG; CODON; GENES, RAS; HUMANS; LUNG NEOPLASMS; NEOPLASM STAGING; NEOPLASMS, SECOND PRIMARY; POINT MUTATION; POLYMERASE CHAIN REACTION; RISK FACTORS;

EID: 0030888691     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Parker, S. L.,Tong, T.,Bolden, S.,and Wingo, P. A. Cancer statistics, 1996. CA Cancer J. Clin.,65:5-27, 1996.
2. Birrer, M. J. Translational research and epithelial carcinogenesis: molecular diagnostic assays now- molecular screening assays soon? J. Natl. Cancer Inst.,87:1041-1042, 1995.
3. Sidransky, D. Molecular screening-how long can we afford to wait? J. Natl. Cancer Inst.,87:955-956, 1994.
4. Mulshine, J. L.,and Scott, F. Molecular markers in early cancer detection. New screening tools. Chest Suppl.,107: 280S-286S, 1995.
5. Slebos, R. J.,and Rodenhuis, S. The ras gene family in human non-small-cell lung cancer. Mongr. Natl. Cancer Inst.,13:23-29, 1992.
6. Suzuki, Y.,Orita, M.,Shiraishi, M.,Hayashi, K.,and Sekiya, T. Detection of ras gene mutations in human lung cancers by single-strand conformation polymorphism analysis of polymerase chain reaction products. Oncogene. 5:1037-1043, 1990.
7. Kumar, R.,and Dunn, L. L. Designed diagnostic restriction fragment length polymorphisms for the detection of point mutations in ras oncogenes. Oncogene Res.,1: 235-241, 1989.
8. Jacobson, D. R.,and Mills, N. E. A highly sensitive assay for mutant ras genes and its application to the study of presentation and relapse genotypes in acute leukemia. Oncogene, 9:553-563, 1994.
9. Mills, N. E.,Fishman, C. L.,Rom, W. N.,Dubin, N.,and Jacobson, D. R. Increased prevalence of K-ras oncogene mutations in lung adenocarcinoma. Cancer Res.,55:1444-1447, 1995.
10. Mills, N. E.,Fishman, C. L, Scholes, J.,Anderson, S. E.,Rom, W. N.,and Jacobson, D. R. Detection of K-ras oncogene mutations in bronchoalveolar lavage fluid for lung cancer diagnosis. J. Natl. Cancer Inst.,87:1056-1059, 1995.
11. Mao, L.,Hruban, R. H.,Boyle, J. O.,Tockman, M.,and Sidransky, D. Detection of oncogene mutations in sputum precedes diagnosis of lung cancer. Cancer Res.,54:1634-1637, 1994.
12. Yakubovskaya, M. S.,Spiegelman, V.,Luo, F. C.,Malaev, S.,Salnev, A.,Zborovskaya, I.,Gasparyan, A.,Polotsky, B.,Machaladze, Z.,Trachtenberg, A. C.,Belitsky, G. A.,and Ronai, Z. High frequency of K-ras mutations in normal appearing lung tissues and sputum of patients with lung cancer. Int. J. Cancer, 63:810-814, 1995.
13. Scott, F.,Cuttitta, F.,Treston, A. M.,Avis, I.,Gupta, P.,Ruckdeschel, J.,Kelly, K.,Piantadosi, S.,Tockman, M.,and Mulshine, J. Prospective trial evaluating immunocytochemical-based sputum techniques for early lung cancer detection: assays for promotion factors in the bronchial lavage. J. Cell. Biochem. Suppl.,17F:175-183, 1993.
14. Sambrook, J.,Fritsch, E. F.,and Maniatis, T. (eds.) Molecular Cloning: A Laboratory Manual, pp. 9.16-9.19. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press, 1989.
15. Gumerlock, P. H.,Poonamallee, U. R.,Meyers, F. J.,and deVere White, R. W. Activated ras alleles in human carcinoma of the prostate are rare. Cancer Res.,51:1632-1637, 1991.
16. Lehman, T. A.,Scott, F.,Seddon, M.,Kelly, K.,Dempsey, E. C.,Wilson, V. L.,Mulshine, J. L.,and Modali, R. Detection of K-ras oncogene mutations by polymerase chain reaction-based ligase chain reaction. Anal. Biochem.,239:153-159, 1996.
17. Wiedmann, M.,Wilson, W. J.,Czajka, J.,Luo, J.,Barany, F.,and Batt, C. A. Ligase chain reaction (LCR) - overview and applications. PCR Methods Applications, 3:S51-S64, 1994.
18. Barany, F. Genetic disease detection and DNA amplification using cloned thermostable ligase. Proc. Natl. Acad. Sci. USA, 88: 189-193, 1991.
19. Tockman, M. S.,Erozan, Y. S.,Gupta, P.,Piantadosi, S.,Mulshine, J. L.,and Ruckdeschel, J. C. The early detection of second primary lung cancers by sputum immunostaining. LCEDWG investigators. Lung cancer early detection working group. Chest Suppl.,106: 385S-390S, 1994.
20. Scott, F. M.,Treston, A. M.,Shaw, G. L.,Avis, I.,Sorenson, J.,Kelly, K.,Dempsey, E. C.,Cantor, A. B.,Tockman, M.,and Mulshine, J. L. Peptide amidating activity in human bronchoalveolar lavage fluid as a potential neuroendocrine marker for early lung cancer detection. Lung Cancer, 14:239-251, 1996.
21. Finney, R. E.,and Bishop, J. M. Predisposition to neoplastic transformation caused by gene replacement of H-ras1. Science (Washington DC), 260:1524-1527, 1993.
22. Parada, L. F.,Land, H.,Weinberg, R. A.,Wolf, D.,and Rotter, V. Cooperation between gene encoding p53 tumour antigen and ras in cellular transformation. Nature (Lond.), 312:649-651, 1984.
23. Westra, W. H.,Baas, I. O.,Hruban, R. H.,Askin, F. B.,Wilson, K.,Offerhaus, G. J. A.,and Slebos, R. J. K-ras oncogene activation in atypical alveolar hyperplasias of the human lung. Cancer Res.,56: 2224-2228, 1996.
24. Sugio, K.,Kishimoto, Y.,Virmani, A. K.,Hung, J. Y.,and Gazdar, A. F. K-ras mutations are a relatively late event in the pathogenesis of lung carcinomas. Cancer Res.,54:5811-5815, 1994.
25. Li, Z. H.,Zheng, J.,Weiss, L. M.,and Shibata, D. c-K-ras and p53 mutations occur very early in adenocarcinoma of the lung. Am. J. Pathol.,144:303-309, 1994.
26. Brentnall, T. A.,Chen, R.,Lee, J. G.,Kimmey, M. B.,Bronner, M. P.,Haggitt, R. C.,Kowdley, K. V.,Hecker, L. M.,and Byrd, D. R. Microsatellite instability and K-ras mutations associated with pancreatic adenocarcinoma and pancreatitis. Cancer Res.,55: 4264-4267, 1995.
27. Tobi, M.,Luo, F. C.,and Ronai, Z. Detection of K-ras mutations in colonic effluent samples from patients without evidence of colorectal carcinoma. J. Natl. Cancer Inst.,86: 1007-1010, 1994.